|
Teva Respiratory Provides Resources for Patients Impacted by PRIMATENE(R) MIST …
MarketWatch (press release) As a result of the removal of Primatene(R) Mist from the market, patients will need to see a healthcare professional to switch to another asthma medication. To help patients in this transition, Teva Respiratory is supporting patients through several … |
View full post on asthma – Google News